Science Access is pleased to welcome you all for "2nd International Conference on Neurology and Brain Disorders ” which will be held during June 18-20, 2018 at Edinburgh, Scotland. The theme of the conference is “Advanced technology and challenges in neurology and brain disorders”.
This meeting deals with the current research developments in the field of Neurology and also about the new treatment methods which are devised by scientists to treat various diseases in easier way. This meeting acts as a best platform for attendees to learn about the recent trends in Neuroscience research and development.
Market Analysis of Neurology
Global neurology devices market is expected to reach USD 10.8 billion by 2022, according to a report by Grand View Research, Inc. This expected growth in demand can be ascribed to growing need for development of different neurostimulation techniques with efficient and accurate algorithms for treatment of several CNS associated disorders.
Rise in incidence of cerebral stroke and other severe disorders such as Parkinsonism, epilepsy, and Alzheimer’s disease is expected to fuel demand of neurology devices thereby driving industry growth. According to National Institute of Neurological Disorders and Stroke (NINDS), approximately 50 million Americans are affected due to these disorders leading to high economic & disease costs burden for medical expenses coupled with loss of productivity.
Interventional neurology can be defined as a specialty wishing to treating major diseases of the brain, spine, and neck, through minimally invasive image guided techniques. Major diseases treated by interventional neurologists include cerebral aneurysm, head and neck tumors, intracranial atherosclerosis, meningiomas, ischemic strokes, spinal vascular malformations, and vertebral body tumors. Intracranial aneurysm, such as subarachnoid hemorrhage, is one of the common neurological disease affecting over 30,000 people in the U.S. each year and over 2% of the global population. Central nervous system arteriovenous malformations (AVMs) have been reported in over 0.15% of the U.S. population, of which over 90% are supratentorial located. Among these, over 4% of the cerebral AVMs are due to hemorrhagic conversions.
The market analysis of neurology represents the largest and untapped market in medicine sector. This estimated market analysis is based on probability of approval and sales of products in late stage development, demographic trends and marketing of product. Emerging markets once again helps to boost revenues. CNS therapeutics comprises approximately 15% of total pharmaceutical sales, nearly $30 billion worldwide.